PMEF
PIII icon

Point72 Middle East FZE’s P3 Health Partners PIII Stock Holding History

Point72 Middle East FZE’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-406
Closed -$29.9K – 1792
2023
Q3 		$29.9K Buy
+406
New +$42.1K ﹤0.01% 1287

Other funds holding PIII

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Point72 Middle East FZE's PIII Position: Q4 2023 in Review

Point72 Middle East FZE sold out of P3 Health Partners (PIII) in Q4 2023, closing a stake of 406 shares — an estimated $29.9K sold.

Point72 Middle East FZE first reported a position in PIII in Q3 2023 and held it in 1 quarter. The position peaked at $29.9K in Q3 2023. 66 funds tracked by Wall St. Rank hold PIII as of Q4 2023.

  • Point72 Middle East FZE reported no remaining P3 Health Partners position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 406 P3 Health Partners shares in Q4 2023, an estimated $29.9K.
  • Point72 Middle East FZE first reported a position in P3 Health Partners in Q3 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's P3 Health Partners position peaked at $29.9K in Q3 2023.
  • 66 funds tracked by Wall St. Rank held P3 Health Partners as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.